Asbestos and lung disease

American Journal of Respiratory Cell and Molecular Biology

Volumn 42, Issue 2, 2010, Pages 131-132

  Brody, Arnold R ^a  

^a NORTH CAROLINA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS; COMPLEMENT COMPONENT C5A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; OXIDIZING AGENT; REACTIVE SULFUR SPECIES; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ASBESTOSIS; CARCINOGENESIS; CELL PROLIFERATION; DOUBLE STRANDED DNA BREAK; EDITORIAL; EXPERIMENTAL MODEL; GENE EXPRESSION; LUNG CANCER; LUNG DISEASE; MALIGNANT MESOTHELIOMA; ONCOGENE C FOS; PROTO ONCOGENE;

ASBESTOS; ASBESTOSIS; HUMANS; LUNG DISEASES; LUNG NEOPLASMS; MESOTHELIOMA; OXIDANTS;

EID: 74549133969     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-2002ED     Document Type: Editorial

References (31)

1. Heintz NH, Janssen-Heininger YM, Mossman BT. Asbestos, lung cancers, and mesotheliomas: from molecular approaches to targeting tumor survival pathways. Am J Respir Cell Mol Biol 2010;42:133-139.
2. Janssen YM, Heintz NH, Marsh JP, Borm PJ, Mossman BT. Induction of c-fos and c-jun proto-oncogenes in target cells of the lung and pleura by carcinogenic fibers. Am J Respir Cell Mol Biol 1994;11:522-530.
3. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North West Cape Province. Br J Ind Med 1960;17:260-272.
4. Brody AR, Hill LH, Adkins B, O'Connor RW. Chrysotile asbestos inhalation in rats: deposition pattern and reaction of alveolar epithelium and pulmonary macrophages. Am Rev Respir Dis 1981;123:670-679.
5. Spees JL, Pociask DA, Sullivan DE, Prockop DJ, Brody AR. Bone Marrow Progenitor Cells Migrate, Proliferate and Differentiate During Asbestos-Induced Pulmonary Fibrosis. Am J Respir Crit Care Med 2007;176:385-394.
6. Mossman BT, Marsh JP, Sesko A, Hill S, Shatos MA, Doherty J, Petruska J, Adler KB, Hemenway D, Mickey R, et al. Inhibition of lung injury, inflammation, and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am Rev Respir Dis 1990;141:1266-1271.
7. Janssen YM, Marsh JP, Absher MP, Hemenway D, Vacek PM, Leslie KO, Borm PJ, Mossman BT. Expression of antioxidant enzymes in rat lungs after inhalation of asbestos or silica. J Biol Chem 1992;267:10625-10630.
8. Brody AR. Asbestos. In: Comprehensive toxicology, vol. 8: toxicology of the respiratory system. Roth RA, editor. New York: Elsevier Science; 1997. pp. 393-413.
9. Mohr U (editor). Toxic and carcinogenic effects of solid particles in the respiratory tract. Washington, DC: ILSI Press; 1994.
10. Brody AR, Roe MW. Deposition pattern of inorganic particles at the alveolar level in the lungs of rats and mice. Am Rev Respir Dis 1983;128:724-729.
11. Kohyama N, Suzuki Y. Analysis of asbestos fibers in lung parenchyma, pleural plaques and mesothelioma tissues of North American insulation workers. In: Landrigan P, Kazemi H, editors. The third wave of asbestos exposure. Ann NY Acad Sci 1991;643:27-53.
12. Pociask DA, Sime PJ, Brody AR. Asbestos-derived reactive oxygen species activate TGF-β1. Lab Invest 2004;84:1013-1023.
13. Liu J-Y, Sime PJ, Wu T, Warshamana GS, Pociask D, Tsai S-Y, Brody AR. Transforming growth factor-β1 overexpression in tumor necrosis factor-α receptor knockout mice induces fibroproliferative lung disease. Am J Respir Cell Mol Biol 2001;25:3-7.
14. Shukla MN, Rose JL, Ray R, Lathrop KL, Ray A. Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7. Am J Respir Cell Mol Biol 2008;40:643-653.
15. Kim S, Buchlis G, Fridlender ZG, Sun J, Kapoor V, Cheng G, Haas A, Cheung HK, Zhang X, Corbley M, et al. Systemic blockade of transforming growth factor-beta signaling augments the efficacy of immunogene therapy. Cancer Res 2008;68:10247-10256.
16. Sullivan DE, Pociask D, Ferris MB, Brody AR. The latent form of TGF-beta1 is induced by TNF-alpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo. J Immunotoxicol 2008;5:145-149.
17. Janssen-Heininger YM, Macara I, Mossman BT. Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB: requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants. Am J Respir Cell Mol Biol 1999;20:942-952.
18. Sullivan DE, Ferris MB, Nguyen H and Brody AR. TNF-alpha induces TGF-beta1 expression in lung fibroblasts at the transcriptional level via AP-1 activation. J Cell Mol Med 2009;13:1866-1874.
19. Brass D, Hoyle GW, Poovey HG, Liu J-Y, Brody AR. Reduced TNF-α and TGF-β1 expression in the lungs of inbred mice that fail to develop fibroproliferative lesions consequent to asbestos exposure. Am J Pathol 1999;154:853-862.
20. Qi Y, Brody AR, Sullivan DE. Laser capture micro-dissection reveals dose-response of gene expression in situ consequent to asbestos exposure. Int J Exp Pathol 2007;88:415-425.
21. Warheit DB, Hill LH, George G, Brody AR. Time Course of chemotactic factor generation and the macrophage response to asbestos inhalation. Am Rev Respir Dis 1986;134:128-133.
22. Brody AR. Asbestosis and silicosis. In: Interstitial pulmonary and bronchiolar disorders. Lynch J, editor. New York: Informa Healthcare; 2008. pp. 317-328.
23. Adamson IY, Bakowska J. KGF and HGF are growth factors for mesothelial cells in pleural lavage fluid after intratracheal asbestos. Exp Lung Res 2001;27:605-616.
24. Cohen SM, Ellwein LB. Cell proliferation in carcinogenesis. Science 1990;249:1007-1011.
25. Levis J, Loi R, Butnor KJ, Vacek P, Steele C, Mossman BT, Weiss DJ. Decreased asbestos-induced lung inflammation and fibrosis after radiation and bone marrow transplant. Am J Respir Cell Mol Biol 2008;38:16-25.
26. Msiska Z, Pacurari M, Mishra A, Leonard SS, Castranova V, Vallyathan V. DNA double strand breaks by asbestos, silica and titanium dioxide: possible biomarker of carcinogenic potential? Am J Respir Cell Mol Biol (In press) [Epub ahead of print as doi: 10.1165/rcmb.2009-0062oc on 2009 June 5.]
27. Busacca S, Germano S, De Cecco L, Rinaldi M, Comoglio F, Favero F, Murer B, Mutti L, Pierotti M, Gaudino G. MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications. Am J Respir Cell Mol Biol (In press) [Epub ahead of print as doi: 10.1165/rcmb.2009-0060oc on 2009 September 25.]
28. Shukla A, MacPherson MB, Hillegass J, Ramos-Nino ME, Alexeeva V, Vacek PM, Bond JP, Pass HI, Steele C, Mossman BT. Alterations in gene expression in human mesothelial cells correlate with mineral pathogenicity. Am J Respir Cell Mol Biol 2009;41:114-123.
29. Manning CB, Sabo-Attwood T, Robledo RF, Macpherson MB, Rincón M, Vacek P, Hemenway D, Taatjes DJ, Lee PJ, Mossman BT. Targeting the MEK1 cascade in lung epithelium inhibits proliferation and fibrogenesis by asbestos. Am J Respir Cell Mol Biol 2008;38:618-626.
30. Tephly LA, Carter AB. Asbestos-induced MKP-3 expression augments TNF-alpha gene expression in human monocytes. Am J Respir Cell Mol Biol 2008;39:113-123.
31. Kamp DW. Asbestos-induced lung diseases: an update. Transl Res 2009;153:143-152.